Peptide Plug

Age Verification

Peptide Plug is a research and organization tool intended for adults 18 years of age or older. By continuing, you confirm you are at least 18.

Reference only · Not medical advice · For adults 18+ · No dosing information is published here
Peptide Plug
Metabolic / GLP-1

Survodutide — reference

Investigational dual GLP-1/glucagon receptor agonist studied for weight management and MASH.

Regulatory statusInvestigational
Published half-life~6 days
Evidence levelClinical trial
CategoryMetabolic / GLP-1

Regulatory status

Investigational. Investigational (Boehringer Ingelheim/Zealand) and not FDA-approved. Verify current status directly with the FDA.

Reported cautions

⚠ Worth knowing. Glucagon-receptor activity gives it a different side-effect profile from GLP-1-only agents. Do not treat trial information as personal instructions.

Pharmacokinetics

Published figures give an elimination half-life of ~6 days. Boehringer Ingelheim/Zealand Phase 2/3 data; not FDA-approved.

This figure is tagged Clinical trial in our evidence system. This figure comes from published human trial data rather than an approved label. It is real data, but it has not been through regulatory review, and the compound may not be approved for any use. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.

Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →

What Peptide Plug does and does not publish

This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.

Frequently asked

Is Survodutide FDA-approved?
Investigational. Investigational (Boehringer Ingelheim/Zealand) and not FDA-approved. Verify current status directly with the FDA.
What is the half-life of Survodutide?
Published figures give ~6 days. Boehringer Ingelheim/Zealand Phase 2/3 data; not FDA-approved.
How reliable is that half-life figure?
It is tagged “Clinical trial” in our system. This figure comes from published human trial data rather than an approved label. It is real data, but it has not been through regulatory review, and the compound may not be approved for any use.
What cautions are associated with Survodutide?
Glucagon-receptor activity gives it a different side-effect profile from GLP-1-only agents. Do not treat trial information as personal instructions.
Does Peptide Plug publish dosing for Survodutide?
No. This library publishes regulatory status, general context and pharmacokinetics only. Dose, frequency and cycle information is deliberately absent from these public pages — those are clinical decisions, not reference data.
Does Peptide Plug sell Survodutide?
No. We do not sell, supply, source or link to vendors for any compound, and we have no affiliate arrangements with suppliers. Peptide Plug is a tracking and calculation tool.

Related tools

Free, no account required.

Reference information, not medical advice. This page describes regulatory status and published pharmacokinetics. It does not tell you whether to use this compound, how much to use, how often, or whether it is safe for you. Peptide Plug does not sell, supply or source any compound. Those decisions belong to you and a licensed clinician.